ERcast: Clinical Perspectives Podcast Preview

Subscription Required

One Physician's Battle with Addiction

Mizuho Morrison, DO and Neil Rifenbark, MD

Sign in or Subscribe to listen.
5 starson Spotify
Sign in or Subscribe to view.Sign in or Subscribe to view.

The summary below is from an episode of ERcast: Clinical Perspectives

Substance use disorder in physicians is common, underrecognized, and especially relevant in emergency medicine. Addiction is a brain disease marked by prefrontal cortical atrophy, dopamine D2 downregulation, and mesolimbic reward-pathway remodeling, with confidential recovery pathways that allow many clinicians to return safely to practice.

Physician Substance Use Disorder

  • Prevalence and specialty risk: Physician substance use disorder is not rare; roughly 10-15% of physicians are affected over a career, with emergency medicine, anesthesiology, and psychiatry carrying some of the highest risk.
  • Addiction as brain disease: Addiction reflects neurobiologic injury rather than moral failure, with prefrontal cortex atrophy, dopamine D2 receptor downregulation, and mesolimbic reward-pathway reorganization driving compulsive use.
  • Common substances misused: Alcohol is the leading substance, followed by opioids and other prescribed sedating or mood-altering medications, a pattern that often blurs stress relief with self-treatment in clinicians.
  • Drivers of ongoing use: Fear of licensure action, job loss, lawsuits, and shame keeps many physicians hidden long after impairment begins. Dr Rifenbark's lived experience makes that progression worth hearing in the episode.
  • Suicide risk signal: Substance use disorder in physicians travels with a markedly higher suicide burden, including about 40% higher occurrence in male physicians and 130% higher occurrence in female physicians.

Recovery Pathways for Clinicians

  • Physician Health Programs: Physician Health Programs operate in 47 states and provide confidential evaluation, referral, treatment coordination, and monitoring tailored to healthcare professionals returning to practice.
  • Five-year recovery outcomes: PHPs have strong longitudinal results, with 78% of participants remaining substance-free at five years and 71% retaining both licensure and employment.
  • Professional-specific treatment options: Caduceus groups and treatment centers for healthcare professionals address recovery in the context of clinical identity, workplace access, and return-to-duty expectations.
  • Core recovery team: A durable treatment plan usually includes a board-certified addiction medicine specialist, a therapist, and peer recovery support, with practice-specific nuances we get into in the chapter.
  • Medication treatment considerations: Buprenorphine with or without naltrexone remains part of evidence-based addiction care, but physician return-to-work rules vary by state and can complicate practice decisions.

Subscribe to ERcast: Clinical Perspectives to listen to the episode.

References:

  1. Baldisseri MR. Impaired healthcare professional. Crit Care Med. 2007;35(2 Suppl):S106-S116. PMID: 17242598
  2. McLellan AT, Skipper GS, Campbell M, DuPont RL. Five year outcomes in a cohort study of physicians treated for substance use disorders in the United States. BMJ. 2008;337:a2038. Published 2008 Nov 4. PMID: 18984632
  3. Merlo LJ, et al. Reasons for misuse of prescription medication among physicians undergoing monitoring by a physician health program. J Addict Med. 2013;7(5):349-353. PMID: 24089039
  4. Schernhammer ES, Colditz GA. Suicide rates among physicians: a quantitative and gender assessment (meta-analysis). Am J Psychiatry. 2004;161(12):2295-2302. PMID: 15569903
  5. Barber, C, Genres, WM.  Drug and Alcohol Rehab for Doctors Near Me.  American Addiction Centers. May 17, 2023.  Accessed December 5, 2023. https://americanaddictioncenters.org/medical-professionals/substance-abuse-among-doctors-key-statistics

Faculty